SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.
Squamous cell carcinoma (SCC) of the lung is a frequent and aggressive cancer type. Gene amplifications, a known activating mechanism of oncogenes, target the 3q26-qter region as one of the most frequently gained/amplified genomic sites in SCC of various types. Here, we used array comparative genomi...
Guardado en:
Autores principales: | Thomas Hussenet, Soraya Dali, Julien Exinger, Ben Monga, Bernard Jost, Doulaye Dembelé, Nadine Martinet, Christelle Thibault, Joerg Huelsken, Elisabeth Brambilla, Stanislas du Manoir |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3b2ea6dd9484143b1b61997e717f532 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acta Nº263
por: Banco Central de Chile
Publicado: (2019) -
Resolución 263(XII): Planificación y desarrollo = Resolution 263(XII): Planning and development = Résolution 263(XII): Planification et développement
Publicado: (2014) -
Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
por: Inma M. Berenjeno, et al.
Publicado: (2017) -
The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration
por: Thibault Mesplède, et al.
Publicado: (2017) -
LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression
por: Zhen-zhen Chen, et al.
Publicado: (2016)